Viarus, Valeriano .

HRN: 16-40-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/06/2025
05/13/2025
IV
1.5 Gram
Q8h
CAP LR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: